| 時間 | 主題 | ||||
|---|---|---|---|---|---|
13:30 ~ 13:36 |
#1096 High-Grade Undifferentiated Prostate Malignancy in a Young Aboriginal Male: A Case Report
講者:
Rowan Klein Nulend
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Rowan Klein Nulend |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
13:36 ~ 13:42 |
#1098 Hereditary Prostate Cancer: A Case Report of a Cancer Pedigree
講者:
Le Dung Tran
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Le Dung Tran |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
13:42 ~ 13:48 |
#62 Combining percentage prostate-specific antigen reduction and multiparametric magnetic resonance imaging to reduce unnecessary biopsy after focal therapy with high-intensity focused ultrasound for prostate cancer
講者:
Po-Fan Hsieh
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Po-Fan Hsieh |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
13:48 ~ 13:54 |
#1109 Prevalence of prostate cancer among men undergoing TRUS guided prostatic biopsies, with correlation of serum PSA levels and distribution of Gleason grade groups: A single tertiary care centre experience.
講者:
Ragavan Narasimhan
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Ragavan Narasimhan |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
13:54 ~ 14:00 |
#666 Genitourinary toxicity following radiation therapy is not just about haematuria- lessons from 7 years of a specialist radiation cystitis clinic.
講者:
Jonathan Kam
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Jonathan Kam |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:00 ~ 14:06 |
#668 Intraductal Carcinoma in Localised Prostate Cancer is Over-Represented in Patients with No Intraprostatic Uptake Pattern on PSMA PET
講者:
Zein Alhamdani
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Zein Alhamdani |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:06 ~ 14:12 |
#676 Reevaluating Role of Vitamin D in Prostate Cancer Pathology: The Impact of MRI-Guided Staging
講者:
Sarita Chitjaroen
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Sarita Chitjaroen |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:12 ~ 14:18 |
#684 Outcomes of Treatment for Localized Prostate Cancer in a Single Institution: Comparison of Radical Prostatectomy and Radiation Therapy Using Inverse Probability of Treatment Weighting (IPTW) Analysis
講者:
Chih-Wei Chu
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Chih-Wei Chu |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:18 ~ 14:24 |
#776 Accuracy of Targeted Transrectal Ultrasound Prostate Biopsies
講者:
Basil Razi
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Basil Razi |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:24 ~ 14:30 |
#816 A comparison between the Australian Cancer Council optimal care pathway for men with prostate cancer and the actual care in a public tertiary centre in Australia
講者:
Thomas Milton
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Thomas Milton |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:30 ~ 14:36 |
#834 The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer. A Scoping Review.
講者:
David Armany
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
David Armany |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:36 ~ 14:42 |
#579 Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy
講者:
Fumihiko Urabe
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Fumihiko Urabe |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:42 ~ 14:48 |
#704 Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer
講者:
SHENG MA
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
SHENG MA |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:48 ~ 14:54 |
#711 Discovery and Validation of Nitroolefin-Based Covalent GPX4 Inhibitors for Inducing Ferroptosis in Prostate Cancer
講者:
Na Zeng
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Na Zeng |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
||
14:54 ~ 15:00 |
#109 A research of burden and risk factors of prostate diseases from 1990 to 2021 in 21 regions and 204 territories
講者:
Yiqun Tian
座長:
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |
Yiqun Tian |
Takayuki GOTO, Rupert Ouyang, Chia-Cheng Yu |